Clinical Trial Update: Phase 2 Study to Assess the Safety, PK, and PD of Sonefpeglutide (HM15912) in SBS-IF Subjects [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the safety, pharmacokinetics, and pharmacodynamics of Sonefpeglutide (HM15912) in subjects with Short Bowel Syndrome-as…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Short Bowel Syndrome

Drugs mentioned

• Sonefpeglutide (HM15912) (Sonefpeglutide)

Snippet

Sponsor: Hanmi Pharmaceutical Company Limited | Conditions: Short Bowel Syndrome | Phase 2 | Status: RECRUITING